NPI: 1992934749 · RALEIGH, NC 27614 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/14/2009
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 07/14/2009 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,159 | $109K |
| 2019 | 9,364 | $87K |
| 2020 | 6,996 | $29K |
| 2021 | 2,960 | $25K |
| 2022 | 1,985 | $59K |
| 2023 | 526 | $5K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 13,714 | 1,097 | $267K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,683 | 615 | $36K |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,022 | 446 | $6K |
| J1756 | Injection, iron sucrose, 1 mg | 1,401 | 374 | $5K |
| 83540 | 512 | 463 | $0.00 | |
| 85041 | 676 | 609 | $0.00 | |
| 83970 | 350 | 319 | $0.00 | |
| 85048 | 676 | 609 | $0.00 | |
| 83550 | 513 | 463 | $0.00 | |
| 82728 | 444 | 402 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 820 | 739 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 45 | 44 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 15 | 15 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 104 | 75 | $0.00 |
| 90674 | 15 | 15 | $0.00 |